Results
GROUP B
A total of 48 of 94 participants were invited to attend the FDGs with a target of 5–6 participants per group. Participants were allocated to either Group A: vaginal ring and daily pills or Group B: vaginal ring and injectable FDGs. This resulted in 3 FGDs from Group A and 4 FGDs from Group B (Table Demographics, reported sexual behaviour, pregnancy history at enrolment of adolescent women in the UChoose studyUsing survey questionnaires, we calculated each variables values at baselineData is shown as number, Years [median (IQR)], otherwise indicated as Number (%)All participants agreed to complete the modified ORTHO pre-survey prior to the FGDs. Our sample was comprised of Group A—14 participants randomised to use vaginal ring and daily pills, and Group B—19 participants randomised to use vaginal ring and injectable (Table Focus group representation per armPlease note that session 6 was marked as incomplete as we did not have enough participants arrive for the session. The facilitators began the session once a minimum of 3 participants were present